Dyne Therapeutics, Inc. (DYN)
USD 24.56
(-6.12%)
USD 24.56
(-6.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -188.15 Million | -153.64 Million | -119.56 Million | -46.5 Million | -11.83 Million | -4.16 Million |
| Net Income | -235.93 Million | -168.09 Million | -149.29 Million | -59.43 Million | -14.85 Million | -4.81 Million |
| Depreciation & Amortization | 2.46 Million | 1.68 Million | 1.08 Million | 700 Thousand | 271 Thousand | 24 Thousand |
| Deferred income taxes | -22.97 Million | - | 2.58 Million | 12 Thousand | - | - |
| Stock-based compensation | 19.97 Million | 15.17 Million | 17.54 Million | 6.59 Million | 26 Thousand | 1000.00 |
| Change in working capital | 26.3 Million | -5.37 Million | 9.25 Million | 5.11 Million | 1.4 Million | 601 Thousand |
| Other non-cash items | 22 Million | 2.97 Million | -746 Thousand | 514 Thousand | 1.32 Million | 21 Thousand |
| Investing Cash Flow | 83.31 Million | 87.2 Million | -137.89 Million | -45.66 Million | -1.64 Million | -134 Thousand |
| Investments in PPE | -729 Thousand | -3.06 Million | -3.61 Million | -1.16 Million | -1.64 Million | -134 Thousand |
| Acquisitions | 23 Thousand | 34 Thousand | 8000.00 | - | - | - |
| Investment purchases | -44.26 Million | -121.17 Million | -236.72 Million | -44.5 Million | - | - |
| Sales/Maturities of investments | 128.3 Million | 211.44 Million | 102.44 Million | - | - | - |
| Other Investing Activities | -23 Thousand | -34 Thousand | -8000.00 | -44.5 Million | - | - |
| Financing Cash Flow | 54.32 Million | 37.39 Million | 157.82 Million | 380.69 Million | 19.98 Million | 12.42 Million |
| Debt repayment | - | - | - | -10 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 54.32 Million | 36.86 Million | 157.23 Million | 246.38 Million | 19.98 Million | 7000.00 |
| Other Financing Activities | 1.95 Million | 529 Thousand | 584 Thousand | 144.3 Million | 19.98 Thousand | 12.41 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 22.97 Million | -1.23 Million | 13.7 Million | 8.56 Million | 1.68 Million | 635 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.33 Million | -4.14 Million | -4.44 Million | -3.45 Million | -284 Thousand | -34 Thousand |
| Cash at beginning of period | 172.14 Million | 203.51 Million | 303.15 Million | 14.63 Million | 8.12 Million | -4.29 Million |
| Cash at end of period | 121.62 Million | 174.46 Million | 203.51 Million | 303.15 Million | 14.63 Million | 8.12 Million |
| Capital Expenditure | -729 Thousand | -3.06 Million | -3.61 Million | -1.16 Million | -1.64 Million | -134 Thousand |
| Effect of forex changes on cash | 4000.00 | - | - | - | - | 4.29 Million |
| Net cash flow / Change in cash | -50.52 Million | -29.05 Million | -99.63 Million | 288.52 Million | 6.5 Million | 12.42 Million |
| Free Cash Flow | -188.88 Million | -156.71 Million | -123.18 Million | -47.66 Million | -13.48 Million | -4.29 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -65.1 Million | -65.64 Million | -235.93 Million | -66.63 Million | -60.21 Million | -64.9 Million |
| Depreciation & Amortization | 400 Thousand | 386 Thousand | 2.46 Million | 567 Thousand | 431 Thousand | 431 Thousand |
| Deferred income taxes | - | - | -22.97 Million | 727 Thousand | -365 Thousand | -362 Thousand |
| Stock-based compensation | 6.73 Million | 19.9 Million | 19.97 Million | 5.73 Million | 4.87 Million | 4.74 Million |
| Change in working capital | 4.24 Million | -32.82 Million | 26.3 Million | 25.52 Million | 4.5 Million | 4.19 Million |
| Other non-cash items | -988.99 Thousand | 173 Thousand | 22 Million | -921 Thousand | 166 Thousand | 243 Thousand |
| Investing Cash Flow | 11.17 Million | -179.83 Million | 83.31 Million | 26.19 Million | 12.82 Million | 17.23 Million |
| Investments in PPE | -857 Thousand | -191 Thousand | -729 Thousand | -82 Thousand | -167 Thousand | -250 Thousand |
| Acquisitions | - | - | 23 Thousand | 7470.00 | -12.98 Thousand | -17.48 Thousand |
| Investment purchases | -26.3 Million | -181.38 Million | -44.26 Million | 23 Thousand | -9.57 Million | -17.99 Million |
| Sales/Maturities of investments | 38.33 Million | 1.74 Million | 128.3 Million | 26.27 Million | 22.56 Million | 35.47 Million |
| Other Investing Activities | - | -179.64 Thousand | -23 Thousand | -30.47 Thousand | 12.98 Thousand | 17.48 Thousand |
| Financing Cash Flow | 379.86 Million | 408.38 Million | 54.32 Million | 147 Thousand | 454 Thousand | 24.9 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 379.86 Million | 397.47 Million | 54.32 Million | 147 Thousand | 454 Thousand | 24.14 Million |
| Other Financing Activities | 4.28 Million | 408.38 Thousand | 1.95 Million | 602 Thousand | 454.00 | 764 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 7.38 Million | -28.75 Million | 22.97 Million | 21.41 Million | 9.45 Million | -1.36 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.13 Million | -4070.00 | 3.33 Million | 4.11 Million | -4.95 Million | 5.56 Million |
| Cash at beginning of period | 272.03 Million | 123.94 Million | 172.14 Million | 130.27 Million | 169.93 Million | 183.43 Million |
| Cash at end of period | 608.19 Million | 273.95 Million | 121.62 Million | 121.62 Million | 132.6 Million | 169.93 Million |
| Capital Expenditure | -857 Thousand | -191 Thousand | -729 Thousand | -82 Thousand | -167 Thousand | -250 Thousand |
| Effect of forex changes on cash | - | - | 4000.00 | -15.54 Million | - | 15.54 Million |
| Net cash flow / Change in cash | 336.16 Million | 150.01 Million | -50.52 Million | -8.65 Million | -37.32 Million | -13.5 Million |
| Free Cash Flow | -55.72 Million | -78.72 Million | -188.88 Million | -35.08 Million | -50.76 Million | -55.89 Million |
AGSTRA
NVDA
TEXMOPIPES
ICM
PAVMZ
LILA